FDA Issues MDOs for Multiple E-Cigarette Products

Regulations by 2FIRSTS.ai
Jan.24.2024
FDA Issues MDOs for Multiple E-Cigarette Products
FDA issues market refusal orders for multiple products, including e-cigarettes, due to inadequate evidence to protect public health.

According to a report from American media CSNews on January 23rd, the US Food and Drug Administration (FDA) has recently issued Market Denial Orders (MDOs) for multiple products from companies such as Bidi Vapor, Shenzhen Youmi Information Technology Co., Ltd., Fontem US, and Shenzhen IVPS Technology Co., Ltd. These products include Bidi Stick Classic e-cigarettes, Suorin Air rechargeable e-cigarettes, Suorin empty pods, blu PLUS+ e-cigarette batteries, seven types of pre-filled e-liquid for blu PLUS+ e-cigarettes, and 22 different SMOK brand e-cigarette products.

 

The FDA emphasized public health standards that consider the risks and benefits to the entire population when evaluating Pre-Market Tobacco Product Applications (PMTA). After reviewing PMTAs from companies like Bidi Vapor, the FDA determined that these applications lacked sufficient evidence to demonstrate that allowing these products on the market would be beneficial for public health, thus violating the legal standards set by the 2009 Family Smoking Prevention and Tobacco Control Act. 

 

Brian King, director of the FDA's Center for Tobacco Products, stated, "Thorough scientific review is a key pillar of FDA regulation. It is the responsibility of applicants to ensure that PMTAs contain sufficient scientific evidence to meet statutory public health standards, and in these cases, such evidence was lacking."

 

Bidi Vapors, a company well-known for its e-cigarette products, expressed disappointment with the recent decision made by the Food and Drug Administration (FDA), while emphasizing that the impact is limited to just one of their products. Bidi CEO, Niraj Patel stated, "Bidi Vapor is currently evaluating this opinion based on its essence. In the meantime, this decision only affects our 'Classic' or tobacco-flavored product. The remaining 10 flavors are still under scientific review and available for sale. At present, we are exploring legal remedies and expect to provide updates within the next few days. In the meantime, we urge our wholesalers and retail partners to reach out to our sales representatives for any queries they may have.

 

Due to MDO, Bidi, or other companies are prohibited from selling or distributing the products listed in the United States market without FDA risk enforcement action. The FDA may require distributors or retailers to comply with regulations as part of its recent efforts to strengthen enforcement of illegal tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interview: AIRSCREAM on Balancing Compliance and Market Demand Amid the Disposable Vape Crackdown
Interview: AIRSCREAM on Balancing Compliance and Market Demand Amid the Disposable Vape Crackdown
During the Dubai World Vape Show, AIRSCREAM executive Andrew spoke with 2Firsts about the brand’s strategies on compliance, large-capacity products, and nicotine alternatives. He underscored the company’s stance against disposable vapes and its commitment to long-termism and youth protection.
Jul.04
To Curb Youth Smoking, New Zealand Bans Disposable E-Cigarettes Starting June
To Curb Youth Smoking, New Zealand Bans Disposable E-Cigarettes Starting June
Starting June 17, 2025, New Zealand will ban disposable e-cigarettes and tighten rules on advertising and promotions to curb youth use and pollution. Experts support the move but stress the need for strong enforcement and monitoring of the black market.
Jun.16 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
The Korea Association of the Elderly Strongly Backs the National Health Insurance Corporation’s Tobacco Litigation, Calling on Tobacco Companies to Establish a Smoking Damage Fund to Fulfill Their Social Responsibilities.
Jun.11 by 2FIRSTS.ai
UK Shift Work Happiness Report 2025: Vape Shop Employees Rank Highest in Wellbeing
UK Shift Work Happiness Report 2025: Vape Shop Employees Rank Highest in Wellbeing
The UK’s Shift Pulse Report 2025 reveals a decline in overall happiness among shift workers, with the healthcare sector under heavy strain and 37.84% of its employees reporting negative emotions. In contrast, staff in tobacco and vape shops rank highest in wellbeing. The report also notes regional disparities and calls for greater attention to workers’ emotional health.
Jul.10 by 2FIRSTS.ai
Forbes: PMI Ranked Among Top 5 “Net Zero Leaders”
Forbes: PMI Ranked Among Top 5 “Net Zero Leaders”
PMI was ranked among the top five in Forbes’ “Net Zero Leaders,” recognized for driving a smoke-free future, committing to sustainability, and planning expansion into the wellness and healthcare sectors.
Jul.29 by 2FIRSTS.ai